Repotrectinib increases effectiveness of MEK inhibitors in KRAS mutant cancer models.

被引：0
|
作者：
Lee, Nathan V. [1 ]
Deng, Wei [1 ]
Zhai, Dayong [1 ]
Rodon, Laura [1 ]
Parra, Ana [1 ]
Cowell, Jessica [1 ]
Banisadr, Afsheen [1 ]
Zhang, Xin [1 ]
Murray, Brion W. [1 ]
机构：
[1] Turning Point Therapeut, San Diego, CA 92121 USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1104
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Repotrectinib increases effectiveness of MEK inhibitor trametinib in KRAS mutant cancer models via simultaneous SRC/FAK/JAK2 inhibition
    Murray, Brion
    Deng, Wei
    Zhai, Dayong
    Rodon, Laura
    Lee, Nathan
    Cui, J. Jean
    CANCER RESEARCH, 2020, 80 (16)
  • [2] Repotrectinib increases effectiveness of KRAS-G12C inhibitors in KRAS-G12C mutant cancer models via simultaneous SRC/FAK/JAK2 inhibition
    Cui, J. Jean
    Zhai, Dayong
    Deng, Wei
    Rodon, Laura
    Lee, Nathan
    Murray, Brion
    CANCER RESEARCH, 2020, 80 (16)
  • [3] Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer
    Ghosh, Susmita
    Fan, Fan
    Powell, Reid T.
    Roszik, Jason
    Park, Yong Sung
    Stephan, Clifford
    Sebastian, Manu
    Tan, Lin
    Sorokin, Alexey, V
    Lorenzi, Philip L.
    Kopetz, Scott
    Ellis, Lee M.
    Bhattacharya, Rajat
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (08) : 962 - 975
  • [4] Targeting MEK in KRAS mutant lung cancer
    Jaenne, Pasi A.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [5] Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models
    Lee, Michael S.
    Helms, Timothy L.
    Feng, Ningping
    Gay, Jason
    Chang, Qing Edward
    Tian, Feng
    Wu, Ji Y.
    Toniatti, Carlo
    Heffernan, Timothy P.
    Powis, Garth
    Kwong, Lawrence N.
    Kopetz, Scott
    ONCOTARGET, 2016, 7 (26) : 39595 - 39608
  • [6] Dual Targeting of Autophagy and MEK in KRAS Mutant Cancer
    Zhao, Hongyun
    Zheng, Bin
    TRENDS IN CANCER, 2019, 5 (06): : 327 - 329
  • [7] RAF kinase inhibition synergizes with MEK inhibitors in KRAS mutant tumors
    Yen, Ivana
    Klijn, Christiaan
    Shanahan, Frances
    Merchant, Mark
    Orr, Christine
    Hunsaker, Thomas
    Durk, Matthew
    La, Hank
    Zhang, Xiaolin
    Martin, Scott
    Lin, Eva
    Chan, John
    Yu, Yihong
    Gustafson, Amy
    Rudolph, Joachim
    Malek, Shiva
    CANCER RESEARCH, 2017, 77
  • [8] Improve MEK/ERK targeting in mutant KRAS lung cancer
    Chen, Zhao
    Weisberg, Ellen
    Cheng, Katherine
    Kung, Andrew L.
    Bradner, James
    Griffin, James
    Wong, Kwok-Kin
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [9] Back to the Bench? MEK and ERK Inhibitors for the Treatment of KRAS Mutant Lung Adenocarcinoma
    Kohler, Jens
    Catalano, Marco
    Ambrogio, Chiara
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (05) : 558 - 574
  • [10] RAF Suppression Synergizes with MEK Inhibition in KRAS Mutant Cancer Cells
    Lamba, Simona
    Russo, Mariangela
    Sun, Chong
    Lazzari, Luca
    Cancelliere, Carlotta
    Grernrum, Wipawadee
    Lieftink, Cor
    Bernards, Rene
    Di Nicolantonio, Federica
    Bardelli, Alberto
    CELL REPORTS, 2014, 8 (05): : 1475 - 1483
12345